SCHEMBL20199729

SCHEMBL20199729

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4cc5c(cc4c4ccc6ccccc6c43)C3(c4ccccc4-5)c4ccccc4C4(c5ccccc5-c5ccccc54)c4ccccc43)n2)cc1

nearest known ligand 0.31

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
ATM Q13315 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
OPRK1 P41145 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199661 0.96 KDM4E (0.31) KDM4EMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL20199611 0.95 MAPT (0.32) KDM4EMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL23604285 0.92 KDM4E (0.30) KDM4EMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL20199731 0.91 MAPT (0.32) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL20199735 0.88 MAPT (0.36) KDM4EMAPTALDH1A1HPGDTSHR
SCHEMBL20199732 0.88 ALDH1A1 (0.39) KDM4EMAPTALDH1A1HPGDMAPK1
SCHEMBL2603568 0.86 MEN1 (0.36) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL20199660 0.86 MAPT (0.32) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL23739108 0.86 KDM4E (0.30) KDM4EMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL20199733 0.86 ALDH1A1 (0.37) KDM4EMAPTALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-05-11 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same DCX, TERT, TELO2 KDM4E 1392/4885MAPT 1276/4885SMN1; SMN2 121/4885
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME DCX, TERT, TELO2 KDM4E 1392/4885MAPT 1276/4885SMN1; SMN2 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.